To further evaluate whether SIRT1 plays a role in GN-mediated protection against steatosis, HepG2 cells were pretreated with GN and/or the specific SIRT1 antagonist Ex52735 before treatment with ethanol, and TG accumulation was accessed. The gene discussed is SIRT1; the disease is steatosis.